For the purposes of clinical trials, and in clinical practice, it is useful to have an objective and reproducible measure of severity of atopic dermatitis. Since there are no labs that can capture itchiness, scaliness or general impact on quality of life, clinicians must rely on more subjective measures. Currently there are more than 60 tools to assess various symptoms and characteristics of disease, but they vary widely and it is not clear which one is best to use. A recent study reviewed the most commonly...Read More
Patients with psoriasis report that the condition affects many aspects of their overall health and often alter their diet to try to combat some psoriasis symptoms. A recent review study looked at the evidence base for dietary interventions for psoriasis to answer some key questions about the role of diet in psoriatic diseases...Read More.
Treating psoriasis with a systemic biologic therapy is increasingly the standard course of treatment, but little is known about how these therapies affect the elderly. Elderly patients are frequently excluded from biological clinical trials and simply described as a high-risk group for adverse events. This has led to a lack of information about safety and effectiveness in this population...Read More